Report LibraryAll Reports
Datamonitor Healthcare Infectious Diseases Forecast: HIV Pre-Exposure Prophylaxis (PrEP)
July 28, 2020
The HIV prevention market will more than double over the 2020–29 forecast period, with sales in the US, Japan, and five major European markets (France, Germany, Italy, Spain, and the UK) growing from $3.2bn to $6.6bn at a compound annual growth rate of 8.4%. The growth is driven by continued penetration within the at-risk population and a diversification of approved therapies available for HIV prevention.
This Datamonitor Healthcare report contains a Patient-Based Forecast module.
|Indications Covered:||HIV Prevention|